Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of vardenafil on outcome and procedure duration after GreenLight laser ablation for benign prostatic hypertrophy
2006-004633-15Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Vardenafil (Levitra) arm with Placebo arm (2 arms). Primary endpoints: Procedure duration and Clinical outcome after laser ablation. Started Dec 2006; status: completed.
02
Drugs
vardenafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2006-004633-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004633-15.